Owl Creek Asset Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Owl Creek Asset Management’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-95,000	Closed	-$9.49K	–	200
2022 Q4	$9.49K	Sell	95,000 -100,000	-51%	-$6.68K	﹤0.01%	189
2022 Q3	$6K	Hold	195,000	–	–	﹤0.01%	277
2022 Q2	$7K	Hold	195,000	–	–	﹤0.01%	335
2022 Q1	$16K	Hold	195,000	–	–	﹤0.01%	371
2021 Q4	$63K	Hold	195,000	–	–	﹤0.01%	361
2021 Q3	$51K	Hold	195,000	–	–	﹤0.01%	355
2021 Q2	$105K	Hold	195,000	–	–	﹤0.01%	299
2021 Q1	$84K	Sell	195,000 -200,000	-51%	-$188K	﹤0.01%	275
2020 Q4	$545K	Buy	+395,000	New	+$364K	0.02%	90

Other funds holding COEPW

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return

Owl Creek Asset Management's COEPW Position: Q1 2023 in Review

Owl Creek Asset Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q1 2023, closing a stake of 95,000 shares — an estimated $9.49K sold.

Owl Creek Asset Management first reported a position in COEPW in Q4 2020 and held it in 9 quarters. The position peaked at $545K in Q4 2020. 18 funds tracked by Wall St. Rank hold COEPW as of Q1 2023.

Owl Creek Asset Management reported no remaining Coeptis Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
Owl Creek Asset Management sold 95,000 Coeptis Therapeutics Warrants shares in Q1 2023, an estimated $9.49K.
Owl Creek Asset Management first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and held it in 9 quarters.
Owl Creek Asset Management's Coeptis Therapeutics Warrants position peaked at $545K in Q4 2020.
18 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2023.

Based on Owl Creek Asset Management's 13F filing for Q1 2023, filed 15 May 2023.